Reports for STERIMAX INC
Company Name
STERIMAX INC
Totals |
||
Shortage reports |
116 |
|
Actual shortage: | 15 (13%) | |
Anticipated shortage: | 3 (3%) | |
Avoided shortage: | 2 (2%) | |
Resolved: | 96 (83%) | |
Discontinuation Reports |
5 |
|
To be discontinued: | 5 (100%) | |
Discontinued: | 0 (0%) | |
Reversed: | 0 (0%) | |
Late reports |
28 (23%) |
|
Overdue reports |
4 (17%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 3.000G 0.375G | POWDER FOR SOLUTION | Resolved | 2020-03-31 | 2020-04-07 | 110220 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3.000G | POWDER FOR SOLUTION | Resolved | 2024-03-07 | 2024-04-05 | 221595 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.0G 0.5G | POWDER FOR SOLUTION | Resolved | 2017-11-30 | 2018-05-31 | 31394 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.0G 0.5G | POWDER FOR SOLUTION | Resolved | 2020-03-31 | 2020-04-07 | 110223 |
REMIFENTANIL HYDROCHLORIDE FOR INJECTION | 1MG | POWDER FOR SOLUTION | Resolved | 2021-11-16 | 2021-11-25 | 149457 |
REMIFENTANIL HYDROCHLORIDE FOR INJECTION | 1MG | POWDER FOR SOLUTION | Resolved | 2022-02-01 | 2022-10-02 | 153966 |
REMIFENTANIL HYDROCHLORIDE FOR INJECTION | 2MG | POWDER FOR SOLUTION | Resolved | 2022-02-01 | 2022-09-27 | 153969 |
AZITHROMYCIN FOR INJECTION | 500MG | POWDER FOR SOLUTION | Resolved | 2019-02-01 | 2019-04-17 | 74350 |
POLYMYXIN B FOR INJECTION USP | 50MG | POWDER FOR SOLUTION | Actual shortage | 2017-04-27 | 2017-10-05 | 8303 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 12G 1.5G | POWDER FOR SOLUTION | Resolved | 2017-11-23 | 2018-01-27 | 30515 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 12G 1.5G | POWDER FOR SOLUTION | Resolved | 2020-03-31 | 2020-04-07 | 110214 |
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | 10G | POWDER FOR SOLUTION | Resolved | 2017-06-16 | 2017-08-17 | 12947 |
VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP | 10G | POWDER FOR SOLUTION | Resolved | 2022-12-13 | 2023-01-06 | 178276 |
CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Resolved | 2019-03-29 | 2019-05-14 | 80085 |
CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-12 | 162207 |
CEFTAZIDIME FOR INJECTION BP | 1G | POWDER FOR SOLUTION | Resolved | 2023-01-27 | 2023-02-14 | 182605 |
CEFTAZIDIME FOR INJECTION BP | 2G | POWDER FOR SOLUTION | Resolved | 2019-03-29 | 2019-05-14 | 80088 |
CEFTAZIDIME FOR INJECTION BP | 2G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-15 | 162210 |
CEFTAZIDIME FOR INJECTION BP | 6G | POWDER FOR SOLUTION | Resolved | 2017-05-03 | 2017-05-25 | 8810 |
CEFTAZIDIME FOR INJECTION BP | 6G | POWDER FOR SOLUTION | Resolved | 2022-06-09 | 2022-07-12 | 162221 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
STREPTOMYCIN FOR INJECTION USP | 1G | POWDER FOR SOLUTION | To be discontinued | 2023-11-06 | 2023-11-06 | 209235 |
MYCOPHENOLATE MOFETIL FOR INJECTION USP | 500MG | POWDER FOR SOLUTION | To be discontinued | 2024-01-22 | 2024-02-06 | 216963 |
BUPIVACAINE HYDROCHLORIDE INJECTION, USP | 7.5MG | SOLUTION | To be discontinued | 2024-01-15 | 2024-01-15 | 216017 |
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | To be discontinued | 2024-03-22 | 2024-03-22 | 223140 |
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | To be discontinued | 2024-03-22 | 2024-03-22 | 223145 |
Showing 1 to 5 of 5